Raymond James Financial’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Raymond James Financial’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.65M	Sell	91,395 -12,645	-12%	-$368K	﹤0.01%	3126
2025 Q4	$2.95M	Buy	+104,040	New	+$2.83M	﹤0.01%	2944
2025 Q3	–	Sell	-7,032	Closed	-$149K	–	5772
2025 Q2	$149K	Buy	+7,032	New	+$144K	﹤0.01%	4665
2025 Q1	–	Sell	-41,261	Closed	-$888K	–	4877
2024 Q4	$888K	Buy	+41,261	New	+$952K	﹤0.01%	3530

Other funds holding IBBQ

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

WMS Group Folsom, Louisiana $77.5M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Raymond James Financial's IBBQ Position: Q1 2026 in Review

Raymond James Financial reduced its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 12% in Q1 2026, selling an estimated $368K and leaving 91,395 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

Raymond James Financial first reported a position in IBBQ in Q4 2024 and has held it in 4 quarters since. The position peaked at $2.95M in Q4 2025. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

Raymond James Financial held 91,395 shares of Invesco NASDAQ Biotechnology ETF worth $2.65M as of Q1 2026.
Raymond James Financial sold 12,645 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $368K.
Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3126 holding.
Raymond James Financial first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2024 and has held it in 4 quarters since.
Raymond James Financial's Invesco NASDAQ Biotechnology ETF position peaked at $2.95M in Q4 2025.
40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.